Skip to main content

Advertisement

Log in

The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review

  • Systematic Reviews and Meta-analyses
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Defining the benefits of resection of isolated non-colorectal, non-neuroendocrine (NCRNNE) liver metastases is difficult. To better understand the survival benefit in this group of patients, we conducted a systematic review of the previous literature.

Methods

Medline, Web of Knowledge, and manual searches were performed using search terms, such as “liver resection” and “primary tumor.” Inclusion criteria were year > 1990, >five patients, and median survival reported or derived. An expected median survival was calculated from weighted averages of median survivals, and differences were assessed using a permutation test.

Results

A total of 7,857 references were identified. Overall 4,735 abstracts were reviewed; 120 manuscripts evaluated and of these, 73 met the study inclusion criteria. The final population consisted of 3,596 patients with renal (n = 234), ovarian (n = 119), testicular (n = 153), adrenal (n = 90), small bowel (n = 28), gallbladder (n = 21), duodenum (n = 38), gastric (n = 481), pancreatic (n = 55), esophageal (n = 23), head and neck (n = 15), and lung (n = 36) cancers, gastrointestinal stromal tumors (GISTs) (n = 106), cholangiocarcinoma (n = 13), sarcoma (n = 189), and melanoma (n = 643). The greatest expected median was 63 months for genitourinary (GU) primaries (n = 549; range 5.4–142 months) followed by 44.4 months for breast cancer (n = 1,013; range 8–74 months), 22.3 months for gastrointestinal cancer (n = 549; range 5–58 months), and 23.7 months for other tumor types (n = 1,082; range 10–72 months). Using a permutation test, we observed that survival was best for patients with GU primaries followed by that for breast cancer patients. Additionally, we also observed that survival was similar for those with cancer of the GI tract and other primary sites.

Conclusions

There appears to be a benefit to resection for patients with NCRNNE liver metastases. The degree of survival advantage is predicated by primary site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94(7):982–99

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Quan D, Gallinger S, Nhan C, Auer RA, Biagi JJ, Fletcher GG et al (2012) The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery 151(6):860–70

    Article  PubMed  Google Scholar 

  3. Mahmoud N, Bullard DK (2010) Metastasectomy for stage IV colorectal cancer. Dis Colon Rectum 53(7):1080–92

    Article  PubMed  Google Scholar 

  4. Tzeng CW, Aloia TA (2013) Colorectal liver metastases. J Gastrointest Surg : Off J Soc Surg Aliment Tract 17(1):195–201, quiz p −2

    Article  Google Scholar 

  5. Bacchetti S, Bertozzi S, Londero AP, Uzzau A, Pasqual EM (2013) Surgical treatment and survival in patients with liver metastases from neuroendocrine tumors: a meta-analysis of observational studies. Int J Hep 2013:235040

    Google Scholar 

  6. Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC et al (2012) Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg 214(5):769–77

    Article  PubMed  Google Scholar 

  7. Bresadola V, Rossetto A, Adani GL, Baccarani U, Lorenzin D, Favero A et al (2011) Liver resection for noncolorectal and nonneuroendocrine metastases: results of a study on 56 patients at a single institution. Tumori 97(3):316–22

    PubMed  Google Scholar 

  8. Reddy SK, Barbas AS, Marroquin CE, Morse MA, Kuo PC, Clary BM (2007) Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis. J Am Coll Surg 204(3):372–82

    Article  PubMed  Google Scholar 

  9. Cordera F, Rea DJ, Rodriguez-Davalos M, Hoskin TL, Nagorney DM, Que FG (2005) Hepatic resection for noncolorectal, nonneuroendocrine metastases. J Gastrointest Surgery : Off J Soc Surg Aliment Tract 9(9):1361–70

    Article  Google Scholar 

  10. Marudanayagam R, Sandhu B, Perera MT, Taniere P, Coldham C, Bramhall S et al (2011) Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience. HPB : Off J Int Hepato Pancreatol Biliary Assoc 13(4):286–92

    Article  Google Scholar 

  11. Elias D, Lasser PH, Montrucolli D, Bonvallot S, Spielmann M (1995) Hepatectomy for liver metastases from breast cancer. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 21(5):510–3

    Article  CAS  Google Scholar 

  12. Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaing D et al (2003) Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol 10(6):705–10

    Article  CAS  PubMed  Google Scholar 

  13. You YN, Leibovitch BC, Que FG (2009) Hepatic metastasectomy for testicular germ cell tumors: is it worth it? J Gastrointest Surge : Off J Soc Surg Aliment Tract 13(4):595–601

    Article  Google Scholar 

  14. Merideth MA, Cliby WA, Keeney GL, Lesnick TG, Nagorney DM, Podratz KC (2003) Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol 89(1):16–21

    Article  PubMed  Google Scholar 

  15. de Jong MC, Tsai S, Cameron JL, Wolfgang CL, Hirose K, van Vledder MG et al (2010) Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol 102(3):256–63

    Article  PubMed  Google Scholar 

  16. Carlini M, Lonardo MT, Carboni F, Petric M, Vitucci C, Santoro R et al (2002) Liver metastases from breast cancer. Results Surg Resection Hepato-Gastroenterol 49(48):1597–601

    Google Scholar 

  17. Gaujoux S, Al-Ahmadie H, Allen PJ, Gonen M, Shia J, D’Angelica M et al (2012) Resection of adrenocortical carcinoma liver metastasis: is it justified? Ann Surg Oncol 19(8):2643–51

    Article  PubMed  Google Scholar 

  18. Mariani P, Piperno-Neumann S, Servois V, Berry MG, Dorval T, Plancher C et al (2009) Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol : J Eur Soc Surg Oncol British Assoc Surg Oncol 35(11):1192–7

    Article  CAS  Google Scholar 

  19. Shima Y, Horimi T, Ishikawa T, Ichikawa J, Okabayashi T, Nishioka Y et al (2003) Aggressive surgery for liver metastases from gastrointestinal stromal tumors. J Hepato-Biliary-Pancreat Surg 10(1):77–80

    Google Scholar 

  20. Hunt TM, Carty N, Johnson CD (1990) Resection of liver metastases from a colorectal carcinoma does not benefit the patient. Ann R Coll Surg Engl 72(3):199–205

    CAS  PubMed Central  PubMed  Google Scholar 

  21. Wang SC, Fidelman N, Nakakura EK (2013) Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver. Semin Oncol 40(1):69–74

    Article  PubMed  Google Scholar 

  22. Schmelzle M, Eisenberger CF, am Esch JS 2nd, Matthaei H, Krausch M, Knoefel WT (2010) Non-colorectal, non-neuroendocrine, and non-sarcoma metastases of the liver: resection as a promising tool in the palliative management. Langenbeck’s Arch Surg Deutsche Gesellschaft fur Chirurgie 395(3):227–34

    Article  Google Scholar 

  23. Di Carlo I (2006) Liver surgery for noncolorectal nonneuroendocrine metastases. HPB : Off J Int Hepato Pancreato Biliary Assoc 8(2):83–4

    Article  Google Scholar 

  24. Lindell G, Ohlsson B, Saarela A, Andersson R, Tranberg KG (1998) Liver resection of noncolorectal secondaries. J Surg Oncol 69(2):66–70

    Article  CAS  PubMed  Google Scholar 

  25. Karavias DD, Tepetes K, Karatzas T, Felekouras E, Androulakis J (2002) Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 28(2):135–9

    Article  CAS  Google Scholar 

  26. Benevento A, Boni L, Frediani L, Ferrari A, Dionigi R (2000) Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol 74(1):24–9

    Article  CAS  PubMed  Google Scholar 

  27. van Ruth S, Mutsaerts E, Zoetmulder FA, van Coevorden F (2001) Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 27(7):662–7

    Article  Google Scholar 

  28. O'Rourke TR, Tekkis P, Yeung S, Fawcett J, Lynch S, Strong R et al (2008) Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 15(1):207–18

    Article  PubMed  Google Scholar 

  29. Yamada H, Katoh H, Kondo S, Okushiba S, Morikawa T (2001) Hepatectomy for metastases from non-colorectal and non-neuroendocrine tumor. Anticancer Res 21(6A):4159–62

    CAS  PubMed  Google Scholar 

  30. Earle SA, Perez EA, Gutierrez JC, Sleeman D, Livingstone AS, Franceschi D et al (2006) Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg 203(4):436–46

    Article  PubMed  Google Scholar 

  31. Hamy AP, Paineau JR, Mirallie EC, Bizouarn P, Visset JP (2000) Hepatic resections for non-colorectal metastases: forty resections in 35 patients. Hepato-Gastroenterology 47(34):1090–4

    CAS  PubMed  Google Scholar 

  32. Hemming AW, Sielaff TD, Gallinger S, Cattral MS, Taylor BR, Greig PD et al (2000) Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transplant : Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 6(1):97–101

    Article  CAS  Google Scholar 

  33. Lendoire J, Moro M, Andriani O, Grondona J, Gil O, Raffin G et al (2007) Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB : Off J Int Hepato Pancreato Biliary Assoc 9(6):435–9

    Article  CAS  Google Scholar 

  34. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, Plaud B, Ducreux M, Spielmann M et al (1998) Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. Journal of the American College of Surgeons 187(5):487–93

    Article  CAS  PubMed  Google Scholar 

  35. Yedibela S, Gohl J, Graz V, Pfaffenberger MK, Merkel S, Hohenberger W et al (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 12(10):778–85

    Article  PubMed  Google Scholar 

  36. Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244(4):524–35

    PubMed Central  PubMed  Google Scholar 

  37. Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D'Angelica M, Harrison LE et al (2005) Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 241(2):269–76

    Article  PubMed Central  PubMed  Google Scholar 

  38. Slotta JE, Schuld J, Distler S, Richter S, Schilling MK, Kollmar O (2014) Hepatic resection of non-colorectal and non-neuroendocrine liver metastases - survival benefit for patients with non-gastrointestinal primary cancers—a case-controlled study. Int J Surg 12(2):163–8

    Article  PubMed  Google Scholar 

  39. Maluccio M, Einhorn LH, Goulet RJ (2007) Surgical therapy for testicular cancer metastatic to the liver. HPB : Off J Int Hepato Pancreato Biliary Assoc 9(3):199–200

    Article  Google Scholar 

  40. Temkin SM, Fleming G (2009) Current treatment of metastatic endometrial cancer. Cancer Control : J Moffitt Cancer Cent 16(1):38–45

    Google Scholar 

  41. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol : Off J Am Soc Clin Oncol 17(8):2530–40

    CAS  Google Scholar 

  42. Maksan SM, Lehnert T, Bastert G, Herfarth C (2000) Curative liver resection for metastatic breast cancer. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 26(3):209–12

    Article  CAS  Google Scholar 

  43. Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S et al (2006) Is liver resection justified for patients with hepatic metastases from breast cancer? Annals of surgery 244(6):897–907, discussion −8

    Article  PubMed Central  PubMed  Google Scholar 

  44. Chua TC, Saxena A, Liauw W, Chu F, Morris DL (2011) Hepatic resection for metastatic breast cancer: a systematic review. Eur J Cancer 47(15):2282–90

    Article  PubMed  Google Scholar 

  45. D'Annibale M, Piovanello P, Cerasoli V, Campioni N (2005) Liver metastases from breast cancer: the role of surgical treatment. Hepato-gastroenterology 52(66):1858–62

    PubMed  Google Scholar 

  46. Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP (1994) The regional treatment of liver metastases from breast cancer. J Surg Oncol 55(1):26–31, discussion 2

    Article  CAS  PubMed  Google Scholar 

  47. Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA (2000) Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127(4):383–9

    Article  CAS  PubMed  Google Scholar 

  48. van Walsum GA, de Ridder JA, Verhoef C, Bosscha K, van Gulik TM, Hesselink EJ et al (2012) Resection of liver metastases in patients with breast cancer: survival and prognostic factors. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 38(10):910–7

    Article  Google Scholar 

  49. Hoffmann K, Franz C, Hinz U, Schirmacher P, Herfarth C, Eichbaum M et al (2010) Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol 17(6):1546–54

    Article  PubMed  Google Scholar 

  50. Pocard M, Pouillart P, Asselain B, Salmon R (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 26(2):155–9

    Article  CAS  Google Scholar 

  51. Mariani P, Servois V, De Rycke Y, Bennett SP, Feron JG, Almubarak MM et al (2013) Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 39(12):1377–83

    Article  CAS  Google Scholar 

  52. Ghosn M, Kourie HR, El Karak F, Hanna C, Antoun J, Nasr D (2014) Optimum chemotherapy in the management of metastatic pancreatic cancer. World J Gastroenterol : WJG 20(9):2352–7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg ME, Splinter TA et al (2003) Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer 89(11):2045–50

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Takemura N, Saiura A, Koga R, Arita J, Yoshioka R, Ono Y et al (2012) Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbeck’s arch Surg Deutsche Gesellschaft fur Chirurgie 397(6):951–7

    Article  Google Scholar 

  55. Sakamoto Y, Sano T, Shimada K, Esaki M, Saka M, Fukagawa T et al (2007) Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95(7):534–9

    Article  PubMed  Google Scholar 

  56. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T et al (1994) Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81(8):1175–8

    Article  CAS  PubMed  Google Scholar 

  57. Zacherl J, Zacherl M, Scheuba C, Steininger R, Wenzl E, Muhlbacher F et al (2002) Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg : Off J Soc Surg Aliment Tract 6(5):682–9

    Article  Google Scholar 

  58. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H et al (2001) Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181(3):279–83

    Article  CAS  PubMed  Google Scholar 

  59. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H et al (2002) Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235(1):86–91

    Article  PubMed Central  PubMed  Google Scholar 

  60. Schildberg CW, Croner R, Merkel S, Schellerer V, Muller V, Yedibela S et al (2012) Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis. World J Surg 36(4):872–8

    Article  PubMed  Google Scholar 

  61. Roh HR, Suh KS, Lee HJ, Yang HK, Choe KJ, Lee KU (2005) Outcome of hepatic resection for metastatic gastric cancer. Am Surg 71(2):95–9

    PubMed  Google Scholar 

  62. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K et al (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133(5):507–11

    Article  PubMed  Google Scholar 

  63. Garancini M, Uggeri F, Degrate L, Nespoli L, Gianotti L, Nespoli A et al (2012) Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile? HPB : Off J Int Hepato Pancreato Biliary Assoc 14(3):209–15

    Article  Google Scholar 

  64. Wang YN, Shen KT, Ling JQ, Gao XD, Hou YY, Wang XF et al (2012) Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg 12:20

    Article  PubMed Central  PubMed  Google Scholar 

  65. Ryu SW, Saw R, Scolyer RA, Crawford M, Thompson JF, Sandroussi C (2013) Liver resection for metastatic melanoma: equivalent survival for cutaneous and ocular primaries. J Surg Oncol 108(2):129–35

    Article  PubMed  Google Scholar 

  66. Chua TC, Chu F, Morris DL (2011) Outcomes of single-centre experience of hepatic resection and cryoablation of sarcoma liver metastases. Am J Clin Oncol 34(3):317–20

    Article  PubMed  Google Scholar 

  67. Raab R, Nussbaum KT, Behrend M, Weimann A (1998) Liver metastases of breast cancer: results of liver resection. Anticancer Res 18(3C):2231–3

    CAS  PubMed  Google Scholar 

  68. Seifert JK, Weigel TF, Gonner U, Bottger TC, Junginger T (1999) Liver resection for breast cancer metastases. Hepato-Gastroenterology 46(29):2935–40

    CAS  PubMed  Google Scholar 

  69. Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F (2000) Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 59(2):177–84

    Article  CAS  PubMed  Google Scholar 

  70. Kondo S, Katoh H, Omi M, Hirano S, Ambo Y, Tanaka E et al (2000) Hepatectomy for metastases from breast cancer offers the survival benefit similar to that in hepatic metastases from colorectal cancer. Hepato-Gastroenterology 47(36):1501–3

    CAS  PubMed  Google Scholar 

  71. Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ et al (2004) Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11(9):869–74

    Article  PubMed  Google Scholar 

  72. Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N et al (2005) Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 29(4):524–7

    Article  PubMed  Google Scholar 

  73. Thelen A, Benckert C, Jonas S, Lopez-Hanninen E, Sehouli J, Neumann U et al (2008) Liver resection for metastases from breast cancer. J Surg Oncol 97(1):25–9

    Article  PubMed  Google Scholar 

  74. Lubrano J, Roman H, Tarrab S, Resch B, Marpeau L, Scotte M (2008) Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38(4):293–9

    Article  PubMed  Google Scholar 

  75. Caralt M, Bilbao I, Cortes J, Escartin A, Lazaro JL, Dopazo C et al (2008) Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol 15(10):2804–10

    Article  PubMed  Google Scholar 

  76. Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V et al (2012) Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 151(5):710–6

    Article  PubMed Central  PubMed  Google Scholar 

  77. Taniguchi H, Takahashi T, Sawai K, Yamaguchi T, Hagiwara A, Kitamura K et al (1997) Comparison in survival between hepatic metastases of gastric and colorectal cancers. Hepato-Gastroenterology 44(15):897–900

    CAS  PubMed  Google Scholar 

  78. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A et al (1997) Hepatic resection of liver metastases from gastric carcinoma. Am JGastroenterol 92(3):490–3

    CAS  Google Scholar 

  79. ]Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A et al (2001) A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96(11):3178–84

    Article  CAS  PubMed  Google Scholar 

  80. Saiura A, Umekita N, Inoue S, Maeshiro T, Miyamoto S, Matsui Y et al (2002) Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepato-Gastroenterology 49(46):1062–5

    PubMed  Google Scholar 

  81. Miki Y, Fujitani K, Hirao M, Kurokawa Y, Mano M, Tsujie M et al (2012) Significance of surgical treatment of liver metastases from gastric cancer. Anticancer Res 32(2):665–70

    PubMed  Google Scholar 

  82. Hemming AW, Magliocca JF, Fujita S, Kayler LK, Hochwald S, Zendejas I et al (2010) Combined resection of the liver and pancreas for malignancy. Journal of the American College of Surgeons 210(5):808–14, 14–6

    Article  PubMed  Google Scholar 

  83. Goulet RJ Jr, Hardacre JM, Einhorn LH, Loehrer PJ, Jones JA, Donohue JP et al (1990) Hepatic resection for disseminated germ cell carcinoma. Ann Surg 212(3):290–3, discussion 3–4

    Article  PubMed Central  PubMed  Google Scholar 

  84. Abood G, Bowen M, Potkul R, Aranha G, Shoup M (2008) Hepatic resection for recurrent metastatic ovarian cancer. Am J Surg 195(3):370–3, discussion 3

    Article  PubMed  Google Scholar 

  85. Roh HJ, Kim DY, Joo WD, Yoo HJ, Kim JH, Kim YM et al (2011) Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch Gynecol Obstet 284(5):1223–9

    Article  PubMed  Google Scholar 

  86. Stief CG, Jahne J, Hagemann JH, Kuczyk M, Jonas U (1997) Surgery for metachronous solitary liver metastases of renal cell carcinoma. J Urol 158(2):375–7

    Article  CAS  PubMed  Google Scholar 

  87. Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A et al (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28(4):543–7

    Article  PubMed  Google Scholar 

  88. Ruys AT, Tanis PJ, Iris ND, van Duijvendijk P, Verhoef C, Porte RJ et al (2011) Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol 18(7):1932–8

    Article  PubMed Central  PubMed  Google Scholar 

  89. Langan RC, Ripley RT, Davis JL, Prieto PA, Datrice N, Steinberg SM et al (2012) Liver directed therapy for renal cell carcinoma. J Cancer 3:184–90

    Article  PubMed Central  PubMed  Google Scholar 

  90. DeMatteo RP, Shah A, Fong Y, Jarnagin WR, Blumgart LH, Brennan MF (2001) Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 234(4):540–7, discussion 7–8

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  91. Nunobe S, Sano T, Shimada K, Sakamoto Y, Kosuge T (2005) Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas. Jpn J Clin Oncol 35(6):338–41

    Article  PubMed  Google Scholar 

  92. Xia L, Zhang MM, Ji L, Li X, Wu XT (2010) Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors. Surg Today 40(10):936–42

    Article  CAS  PubMed  Google Scholar 

  93. Zacherl M, Bernhardt GA, Zacherl J, Gruber G, Kornprat P, Bacher H et al (2011) Surgery for liver metastases originating from sarcoma-case series. Langenbeck’s Arch Surg Deutsche Gesellschaft fur Chirurgie 396(7):1083–91

    Article  Google Scholar 

  94. Salmon RJ, Levy C, Plancher C, Dorval T, Desjardins L, Leyvraz S et al (1998) Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy. Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol 24(2):127–30

    Article  CAS  Google Scholar 

  95. Rose DM, Essner R, Hughes TM, Tang PC, Bilchik A, Wanek LA et al (2001) Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch Surg 136(8):950–5

    Article  CAS  PubMed  Google Scholar 

  96. Hsueh EC, Essner R, Foshag LJ, Ye X, Wang HJ, Morton DL (2004) Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer 100(1):122–9

    Article  PubMed  Google Scholar 

  97. Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, Negrier S, Grange JD (2005) Treatment of liver metastases from uveal melanoma. Ann Surg Oncol 12(6):422–8

    Article  PubMed  Google Scholar 

  98. Kodjikian L, Grange JD, Baldo S, Baillif S, Garweg JG, Rivoire M (2005) Prognostic factors of liver metastases from uveal melanoma. Graefe’s Arch Clin Exp Ophthalmol = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 243(10):985–93

    Article  Google Scholar 

  99. Herman P, Machado MA, Montagnini AL, D'Albuquerque LA, Saad WA, Machado MC (2007) Selected patients with metastatic melanoma may benefit from liver resection. World J Surg 31(1):171–4

    Article  PubMed  Google Scholar 

  100. Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI et al (2006) Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 13(5):712–20

    Article  PubMed  Google Scholar 

  101. Frenkel S, Nir I, Hendler K, Lotem M, Eid A, Jurim O et al (2009) Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol 93(8):1042–6

    Article  CAS  PubMed  Google Scholar 

  102. Woon WW, Haghighi KS, Zuckerman RS, Morris DL (2008) Liver resection and cryotherapy for metastatic melanoma. Int Surg 93(5):274–7

    CAS  PubMed  Google Scholar 

  103. Du SD, Mao YL, Li SH, Sang XT, Lu X, Xu YY et al (2012) Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma. World J Hepatol 4(11):305–10

    Article  PubMed Central  PubMed  Google Scholar 

  104. Ripley RT, Kemp CD, Davis JL, Langan RC, Royal RE, Libutti SK et al (2011) Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol 18(7):1972–9

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

Timothy L. Fitzgerald has had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Timothy L. Fitzgerald.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fitzgerald, T.L., Brinkley, J., Banks, S. et al. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg 399, 989–1000 (2014). https://doi.org/10.1007/s00423-014-1241-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-014-1241-3

Keywords

Navigation